AIxBio White Paper 3: Risks of AIxBio

Policymakers should carefully consider the nuances of the risks associated with artificial intelligence (AI) models that interact with biotechnology (AIxBio) when considering oversight mechanisms, like regulation, in order to promote safe and secure innovation without stifling advancement of the technology. This white paper provides a current snapshot of specific information related to AIxBio and risk and describes the concerns associated with different categories of AI tools.  

Read the rest of the papers in this series here.